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Purpose
• NASA needs to understand risk of CVD outcomes among 
astronauts 
• Inform HRP and Space Medicine
• NASA needs to understand any interactions between the 
occupational health effects of spaceflight exposure and 
normal aging 
• Guide occupational surveillance of astronauts in the future
Perhon, et al, 2001
Cardiovascular Alterations of Spaceflight
Cardiovascular Alterations of Spaceflight
Fig. 1. Carotid distensibility coefficient (cDC using brachial pulse pressure for comparison to
population data) is shown for the astronauts (left) and a reference population (right).
Hughson, et al, 2016
Cardiovascular Alterations of Spaceflight
Incidence of presyncope during stand and tilt testing after short- and long-duration 
flights. Presyncope is defined as the failure to complete 10 minutes of 80° upright tilt 
without symptoms.
Cardiovascular Disease
•Unsure if acute cardiovascular changes translate to 
overt disease
•Combined chronic effects of spaceflight and aging 
are not understood
•Spaceflight-related exposures may increase risk for 
CVD 
• Altered dietary and exercise habits
• Physical/emotional stress
• Circadian rhythm shifts
• Radiation
• Repeated exposures to microgravity
Limited Epidemiological Data on 
Astronauts
• Most recent epidemiological studies on CVD risk were published 
in 2000 (Hamm) and 2005 (Hamilton) 
• No current data published on CVD Outcomes in astronauts
• Need to understand the health risks in astronauts as spaceflight 
exposures evolve
• Short duration missions  Long duration missions (6 months to 1 year) 
 Very Long duration missions (3 years)
NASA does not have a current 
understanding of lifetime CVD risk in the 
astronaut corps
Comparing Astronauts to Other Cohorts
•Comparison to general population hampered by: 
• Selection bias 
•Healthy worker effect
•Health status across time 
• Cohort effect 
• Changes to lifestyle, health and practice of medicine over 60 years
• Small numbers of NASA Astronauts
•We have been actively seeking cohorts to 
compare the astronauts with and all have 
limitations. 
Cohorts Considered for Comparison
• Coronary Artery Risk Development in Young Adults (CARDIA)
• Defense Medical Surveillance System
• Framingham Heart Study
• Dallas Heart Study
• Multi-Ethnic Study of Atherosclerosis (MESA)
• Millennium Cohort
• Prospective Army Coronary Calcium study
• Air Force Aviators
• Cooper Center Longitudinal Study
Study Design
Historical Cohort Study
• Similar to a prospective cohort in that a sample from a population is 
monitored for the exposure of interest and then the outcome of 
interest
• Retrospective Identification of participants in cohort, classifying 
exposure of interest (spaceflight) and then reviewing records for 
outcomes of interest
• Common Occupational Epidemiologic Method 
• Used for rapid execution since do not need to wait for follow up time to accrue 
or study participants to be recruited
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Outcome 
Study Questions
• Are there differences in the incidence of CVD Outcomes 
between each cohort and the NASA Astronaut Corps? 
• MI, Stroke, Revascularization
• Are there differences in the incidence of CVD risks between 
each cohort and the NASA Astronaut cohort? 
• Hypertension, Hyperlipidemia, Arrhythmias, Diabetes
• Are there differences between each cohort and the NASA 
Astronaut cohort in how CVD risk factors change across 
time? 
• Lipid profile
• CV related behaviors – exercise, smoking
Air Force Aviators 
Study Design
Collaborators Eddie Davenport, MD, FACC, Lt Col, United States Air Force
Chief Cardiologist Aeromedical Consultation Service
Study Subjects Current or previous aviator from the USAF 
Sample Size 3-1 Air Force to Astronaut ratio
Inclusion 
Criteria
Aviators with normal ECG at 35 years of age
At least one additional ECG 15 years later 
Exclusion 
Criteria
Any history of CVD prior to age 35 ECG
Matching 
Variables
Year of ECG/Astronaut Selection, Sex
Status Air Force Identified Sample 
USAF IRB Review
Cooper Center Longitudinal Study
Study Design
Collaborators Laura DeFina, MD – President/CEO, The Cooper Institute
Nina Radford, MD – Cardiologist, Cooper Clinic
Carolyn Barlow, PhD – Senior Epidemiologist, The Cooper 
Institute
Study Subjects Current or previous participant in CCLS
Sample Size 3-1 Cooper to Astronaut ratio
Inclusion 
Criteria
At least one exam following CCLS Baseline
Exclusion 
Criteria
Any CVD diagnosis at CCLS Baseline
Matching 
Variables 
Age, Year of Study Entry, Sex, Baseline BMI, Education, 
Employment Status
Status JSC IRB in Progress
Data
• Exposure of Interest
• Spaceflight
• Number of days in space
• Number of missions
• CVD Outcomes
• Primary – MI, revascularization and stroke
• Secondary – HTN, hyperlipidemia, arrhythmias, diabetes
• Changes to risk factors across time
• Covariates (as available at each exam):
• Demographic variables
• Vital signs 
• Laboratory Testing: Lipid, CRP, Fasting glucose, HbA1c, CACs, cIMT
• Medication use
• ECG interpretation
• Behaviors: Exercise, smoking
• Family history of cardiovascular disease
• Military and/or piloting history
Proposed Analyses
• Logistic Regression 
• Dichotomous CVD outcomes
• Odds of having CV outcome different between cohort and astronauts 
• Survival Analysis
• Time to CVD Outcome 
• Differences in time to CVD outcome between cohort and astronauts
Limitations
• Data harmonization within and between different cohorts 
may be difficult 
• Different data collection methods by cohort
• Different data collection methods across time
• Astronaut records initially collected for medical care
• Analyses based on current understanding of cardiovascular 
disease 
• As with any cohort, changes to how disease is diagnosed and 
managed across time
• Accounting for those changes by using comparable birth cohorts 
that are followed longitudinally
• Differences in the way astronauts are selected versus how 
either cohort creates bias
Study Team
Lifetime Surveillance of Astronaut Health
• Jacqueline Charvat, PhD
• Mary Van Baalen, PhD
JSC Cardiovascular and Vision Laboratory
• Stuart M.C. Lee, PhD
• Michael B. Stenger, PhD
United States Air Force
• Eddie Davenport, MD 
Cooper Clinic
• Carolyn Barlow, PhD 
• Laura DeFina, MD
• Nina Radford, MD 
Questions?
Back up
Strength of Cohorts Chosen
• Air Force 
• Aviators and astronauts chosen for health status
• Cooper Center Longitudinal Study
• Breadth of cardiac measures on participants
Air Force Aviators 
• Dr. Eddie Davenport, MD, FACC, Lt Col, USAF
• Chief Cardiologist Aeromedical Consultation Service at Wright Patterson Air 
Force Base in Dayton, OH
• Study Subjects
• Current or previous aviator from the US Air Force
• Inclusion Criteria 
• Aviators with normal EKG at 35 years 
• Aviators who then had at least one additional EKG ~ 15 years following
• Exclusion Criteria
• Aviators with any history of CVD prior to age 35 EKG
• Matching
• Random sample of aviators who meet criteria will be 
• Matched 3-1 by year and gender
• Current Status 
• Air Force has identified an aviator sample 
• Currently at USAF IRB review 
Cooper Center Longitudinal Study
• Laura DeFina, MD – President/CEO, The Cooper Institute
• Nina Radford, MD – Cardiologist, Cooper Clinic
• Carolyn Barlow, PhD – Senior Epidemiologist, The Cooper 
Institute
• Study Subjects
• Current or previous participant in CCLS with at least one exam 
following baseline
• Inclusion Criteria 
• Exclusion Criteria
• Any CVD diagnosis at baseline 
• Matching
• Age, year of selection, gender, Baseline BMI, education and 
employment
• Random sample of cohort members who meet criteria will be 
matched 3-1
• Current Status: JSC IRB in process
